Literature DB >> 13343012

Use of tranquilizers in diseases of the skin; a preliminary report.

P LEVAN, E T WRIGHT.   

Abstract

Tranquilizing agents such as chlorpromazine and reserpine were used in various diseases of the skin in which the psychogenic factors were considered important etiologic agents. While a tranquilizing effect was obtained in the majority of instances, the side reactions and variation in response were so great as to render these agents unsatisfactory for routine use as tranquilizers. Meprobamate (marketed under the trade names Miltown and Equanil) was then used on a group of dermatologic patients with more consistent tranquilizing effect and comparatively little unpleasant side reactions. It is felt that further study of the use of meprobamate as a tranquilizing agent in dermatology is worth while.

Entities:  

Keywords:  CHLORPROMAZINE/therapeutic use; MUSCLE RELAXANTS/therapeutic use; RAUWOLFIA ALKALOIDS/therapeutic use; SKIN/diseases

Mesh:

Substances:

Year:  1956        PMID: 13343012      PMCID: PMC1531907     

Source DB:  PubMed          Journal:  Calif Med        ISSN: 0008-1264


  5 in total

1.  Clinical study of a new tranquilizing drug; use of miltown (2-methyl-2-n-propyl-1,3-propanediol dicarbamate).

Authors:  L S SELLING
Journal:  J Am Med Assoc       Date:  1955-04-30

2.  Clinical investigation in dermatology.

Authors:  C S LIVINGOOD
Journal:  J Invest Dermatol       Date:  1955-10       Impact factor: 8.551

3.  Personality and emotional factors in chronic disseminated neurodermatitis.

Authors:  C E FISKE; M E OBERMAYER
Journal:  AMA Arch Derm Syphilol       Date:  1954-09

4.  Experimental controls in clinical dermatologic investigation.

Authors:  D M PILLSBURY; M C ZIMMERMAN; G D BALDRIDGE
Journal:  J Invest Dermatol       Date:  1950-05       Impact factor: 8.551

5.  Efficacy of reserpine (serpasil) in dermatological therapy.

Authors:  C R REIN; J J GOODMAN
Journal:  AMA Arch Derm Syphilol       Date:  1954-12
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.